These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 6931255)
1. Pathologic and biochemical effects of azaserine in inbred Wistar/Lewis rats and noninbred CD-1 mice. Roebuck BD; Lilja HS; Curphey TJ; Longnecker DS J Natl Cancer Inst; 1980 Aug; 65(2):383-9. PubMed ID: 6931255 [TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the pancreas in azaserine-treated rats. Longnecker DS; Curphey TJ Cancer Res; 1975 Aug; 35(8):2249-58. PubMed ID: 1097106 [TBL] [Abstract][Full Text] [Related]
3. Species and rat strain variation in pancreatic nodule induction by azaserine. Roebuck BD; Longnecker DS J Natl Cancer Inst; 1977 Oct; 59(4):1273-7. PubMed ID: 302864 [TBL] [Abstract][Full Text] [Related]
4. Induction of pancreatic carcinomas in rats with N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine: histopathology. Longnecker DS; Roebuck BD; Kuhlmann ET; Curphey TJ J Natl Cancer Inst; 1985 Jan; 74(1):209-17. PubMed ID: 3871492 [TBL] [Abstract][Full Text] [Related]
5. Studies of DNA damage in rat pancreas and liver by 6-diazo-5-oxo-L-norleucine, ethyl diazoacetate and azaserine. Lilja HS; Longnecker DS; Curphey TJ; Daniel DS; Adams WE Cancer Lett; 1981 Mar; 12(1-2):139-46. PubMed ID: 7272997 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Sumi C; Longnecker DS; Roebuck BD; Brinck-Johnsen T Cancer Res; 1989 May; 49(9):2332-6. PubMed ID: 2706621 [TBL] [Abstract][Full Text] [Related]
7. Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat. Roebuck BD; Baumgartner KJ; Thron CD Lab Invest; 1984 Feb; 50(2):141-6. PubMed ID: 6694355 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305). Lhoste EF; Roebuck BD; Longnecker DS Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478 [TBL] [Abstract][Full Text] [Related]
10. Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats. Longnecker DS; Kuhlmann ET; Curphey TJ Cancer Res; 1983 Jul; 43(7):3219-25. PubMed ID: 6601985 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719 [TBL] [Abstract][Full Text] [Related]
12. Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat. Roebuck BD; Yager JD; Longnecker DS Cancer Res; 1981 Mar; 41(3):888-93. PubMed ID: 7459874 [TBL] [Abstract][Full Text] [Related]
13. Response of two rodents, Mastomys natalensis and Mystromys albicaudatus, to the pancreatic carcinogen azaserine. Roebuck BD; Longnecker DS J Natl Cancer Inst; 1979 May; 62(5):1269-71. PubMed ID: 286103 [TBL] [Abstract][Full Text] [Related]
14. A single-dose protocol for azaserine initiation of pancreatic carcinogenesis in the rat. Yager JD; Roebuck BD; Zurlo J; Longnecker DS; Weselcouch EO; Wilpone SA Int J Cancer; 1981 Nov; 28(5):601-6. PubMed ID: 6975760 [TBL] [Abstract][Full Text] [Related]
15. Promotion by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat. Roebuck BD; Yager JD; Longnecker DS; Wilpone SA Cancer Res; 1981 Oct; 41(10):3961-6. PubMed ID: 7285004 [TBL] [Abstract][Full Text] [Related]
16. Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas. Lhoste EF; Longnecker DS Cancer Res; 1987 Jun; 47(12):3273-7. PubMed ID: 3581068 [TBL] [Abstract][Full Text] [Related]
17. Inhibition by retinoids of the growth of azaserine-induced foci in the rat pancreas. Roebuck BD; Baumgartner KJ; Thron CD; Longnecker DS J Natl Cancer Inst; 1984 Jul; 73(1):233-6. PubMed ID: 6610790 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of azaserine by cholestyramine in the rat. Morgan RG; Papadimitriou JM; Crass RA Int J Exp Pathol; 1990 Aug; 71(4):485-91. PubMed ID: 2400737 [TBL] [Abstract][Full Text] [Related]
19. Hyperplastic nodules and adenomas of exocrine pancreas in azaserine-treated rats. Longnecker DS; Crawford BG J Natl Cancer Inst; 1974 Aug; 53(2):573-7. PubMed ID: 4843277 [No Abstract] [Full Text] [Related]
20. Increased immunoreactivity and protein tyrosine kinase activity of the protooncogene pp60c-src in preneoplastic lesions in rat pancreas. Visser CJ; Rijksen G; Woutersen RA; De Weger RA Lab Invest; 1996 Jan; 74(1):2-11. PubMed ID: 8569183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]